Bulk Manufacturer of Controlled Substances Application: Stepan Company, 54849 [2016-19592]

Download as PDF Federal Register / Vol. 81, No. 159 / Wednesday, August 17, 2016 / Notices DEPARTMENT OF JUSTICE DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. ODAG 164] [Docket No. DEA–392] Notice of Federal Advisory Committee Meeting Department of Justice. Notice of Federal Advisory Committee meeting. Request for public comment. AGENCY: Bulk Manufacturer of Controlled Substances Application: Stepan Company ACTION: ACTION: Notice of application. The Attorney General has delegated her authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Deputy Assistant Administrator of the DEA Office of Diversion Control (‘‘Deputy Assistant Administrator’’) pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.33(a), this is notice that on April 21, 2016, Stepan Company, Natural Products Dept., 100 W. Hunter Avenue, Maywood, New Jersey 07607 applied to be registered as a bulk manufacturer of the following basic classes of controlled substances: SUPPLEMENTARY INFORMATION: Controlled substance Schedule mstockstill on DSK3G9T082PROD with NOTICES Cocaine (9041) ............................. Ecgonine (9180) ........................... II II The company plans to manufacture the listed controlled substances in bulk for distribution to its customers. Dated: August 10, 2016. Louis J. Milione, Deputy Assistant Administrator. [FR Doc. 2016–19592 Filed 8–16–16; 8:45 am] BILLING CODE 4410–09–P VerDate Sep<11>2014 16:39 Aug 16, 2016 The National Commission on Forensic Science will hold meeting eleven at the time and location listed below. DATES: (1) Public Hearing. The meeting will be held on September 12, 2016 from 12:30 p.m. to 5:15 p.m. and September 13, 2016 from 8:00 a.m. to 4:00 p.m. (2) Written Public Comment. Written public comment regarding National Commission on Forensic Science meeting materials can be submitted through www.regulations.gov starting on August 29, 2016. Any comments should be posted to www.regulations.gov no later than September 28, 2016. ADDRESSES: Location: National Institute of Standards and Technology (NIST), Administrative Building #101, West Square Conference Room, 100 Bureau Drive, Gaithersburg, MD 20899. Please note admittance instructions under the SUPPLEMENTARY INFORMATION section of this notice. FOR FURTHER INFORMATION CONTACT: Jonathan McGrath, Ph.D., Senior Policy Analyst at the National Institute of Justice and Designated Federal Official, 810 7th Street NW., Washington, DC 20531, by email at Jonathan.McGrath@ usdoj.gov by phone at (202) 514–6277. SUPPLEMENTARY INFORMATION: Agenda: Open Meeting: The Commission will meet on September 12, 2016, 12:30 p.m. to 5:15 p.m. and September 13, 2016, 8:00 a.m. to 4:00 p.m. On September 12, the Commission will receive a briefing on technical merit review and Subcommittee status reports. On September 13, the Commission will receive Subcommittee status reports, a briefing on statistical statements of relevance, an update on the Forensic Science Discipline Review from DOJ’s Office of Legal Policy and a discussion of ethics issues for NCFS members from DOJ’s Departmental Ethics Office. Note: agenda items, including designation of presentation dates are subject to change. A final agenda will be posted to the Commission’s Web site in advance of the meeting. Meeting Accessibility: Pursuant to 41 CFR 102–3.140 through 102–3.165 and the availability of space, the meeting scheduled for September 12, 2016, 12:30 SUMMARY: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration in accordance with 21 CFR 1301.33(a) on or before October 17, 2016. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/ODW, 8701 Morrissette Drive, Springfield, Virginia 22152. DATES: Jkt 238001 PO 00000 Frm 00064 Fmt 4703 Sfmt 4703 54849 p.m. to 5:15 p.m. and September 13, 2016, 8:00 a.m. to 4:00 p.m. at NIST is open to the public and webcast. New Visitor Access Requirement: For participants attending in person, please note that federal agencies, including NIST, can only accept a state-issued driver’s license or identification card for access to federal facilities if such license or identification card is issued by a state that is compliant with the REAL ID Act of 2005 (Pub. L. 109–13), or by a state that has an extension for REAL ID compliance. NIST currently accepts other forms of federal-issued identification in lieu of a state-issued driver’s license. Driver’s licenses from six states and territories are not compliant and will not be accepted as identification: Minnesota, Illinois, Missouri, Washington, and American Samoa. In addition, NIST will accept only enhanced driver’s licenses (identified by the American Flag on the face of the card) from two states: Minnesota and Washington State. For a list of alternative identification, please visit: http://www.nist.gov/public_ affairs/visitor/. Non U.S. Citizens Please Note: All foreign national visitors who do not have permanent resident status and who wish to register for the above meeting must supply additional information. Failure to provide this information prior to arrival will result, at a minimum, in significant delays (up to 24 hours) in entering the facility. Authority to gather this information is derived from United States Department of Commerce Department Administrative Order (DAO) number 207–12. When on-line registration is open, the required NIST– 1260 form will be available. The NIST– 1260 form needs to be submitted at least 5 business days in advance of the meeting. Written Comments: Pursuant to section 10(a)(3) of the FACA and 41 CFR 102–3.105(j) and 102–3.140, the public or interested organizations may submit written comments to the Commission in response to the stated agenda and meeting material. Meeting material, including work products will be made available on the Commission’s Web site: http://www.justice.gov/ncfs. Oral Comments: In addition to written statements, members of the public may present oral comments at 5:00 p.m. on September 12, 2016 and at 3:45 p.m. on September 13, 2016. Those individuals interested in making oral comments should indicate their intent through the on-line registration form and time will be allocated on a first-come, first-served basis. Time allotted for an individual’s comment period will be limited to no more than 3 minutes. If the number of E:\FR\FM\17AUN1.SGM 17AUN1

Agencies

[Federal Register Volume 81, Number 159 (Wednesday, August 17, 2016)]
[Notices]
[Page 54849]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-19592]



[[Page 54849]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]


Bulk Manufacturer of Controlled Substances Application: Stepan 
Company

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic classes, and 
applicants therefore, may file written comments on or objections to the 
issuance of the proposed registration in accordance with 21 CFR 
1301.33(a) on or before October 17, 2016.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/ODW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: The Attorney General has delegated her 
authority under the Controlled Substances Act to the Administrator of 
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority 
to exercise all necessary functions with respect to the promulgation 
and implementation of 21 CFR part 1301, incident to the registration of 
manufacturers, distributors, dispensers, importers, and exporters of 
controlled substances (other than final orders in connection with 
suspension, denial, or revocation of registration) has been redelegated 
to the Deputy Assistant Administrator of the DEA Office of Diversion 
Control (``Deputy Assistant Administrator'') pursuant to section 7 of 
28 CFR part 0, appendix to subpart R.
    In accordance with 21 CFR 1301.33(a), this is notice that on April 
21, 2016, Stepan Company, Natural Products Dept., 100 W. Hunter Avenue, 
Maywood, New Jersey 07607 applied to be registered as a bulk 
manufacturer of the following basic classes of controlled substances:

------------------------------------------------------------------------
            Controlled substance                       Schedule
------------------------------------------------------------------------
Cocaine (9041).............................  II
Ecgonine (9180)............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for distribution to its customers.

    Dated: August 10, 2016.
Louis J. Milione,
Deputy Assistant Administrator.
[FR Doc. 2016-19592 Filed 8-16-16; 8:45 am]
 BILLING CODE 4410-09-P